Brief: Aptevo Therapeutics - Enters Amendment No. 6 To Rights Agreement On October 23, 2026 - SEC Filing
23/10/2026 23:15
BRIEF-Aptevo Therapeutics - Enters Amendment No. 6 To Rights Agreement On October 23, 2026 - SEC Filing Oct 23 (Reuters) - Aptevo Therapeutics Inc APVO.O:
APTEVO THERAPEUTICS - ENTERS AMENDMENT NO. 6 TO RIGHTS AGREEMENT ON OCTOBER 23, 2026 - SEC FILING
APTEVO THERAPEUTICS - AMENDMENT EXTENDS FINAL EXPIRATION DATE TO OCTOBER 23, 2027 - SEC FILING
APTEVO THERAPEUTICS - AMENDMENT CHANGES PURCHASE PRICE TO $14.56 PER ONE ONE-THOUSANDTH OF A PREFERRED SHARE - SEC FILING
Source text: [ID:n0001193125-26-430419]
Further company coverage: APVO.O
((((Reuters.Briefs@thomsonreuters.com;));))
Recent news on Aptevo Therapeutics
See all newsBrief: Aptevo Therapeutics - Enters Amendment No. 6 To Rights Agreement On October 23, 2026 - SEC Filing
U.S. STOCKS ON THE MOVE-Principal Financial Group, NetApp
U.S. STOCKS ON THE MOVE-Genesco, Fervo Energy, Tyson Foods
Aptevo Therapeutics reports early data for blood cancer therapy; shares fall
Aptevo Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary